Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-16 Sale | 2024-10-18 6:51 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 1,673,128 | $46.3 | $77,472,371 | 4,281,533 (Indirect Direct) | View |
2024-09-26 Sale | 2024-09-30 8:49 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 307,779 | $46.96 | $14,452,394 | 3,005,777 (Indirect Direct) | View |
2024-09-10 Sale | 2024-09-12 8:42 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 451,091 | $46.89 | $21,153,619 | 5,987,589 (Indirect Direct) | View |
2024-09-06 Sale | 2024-09-10 5:02 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 242,182 | $42 | $10,172,364 | 3,297,625 (Indirect Direct) | View |
2024-06-03 Sale | 2024-06-05 7:19 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. 10% Owner | 1,500,000 | $54.75 | $82,125,000 | 6,611,234 (Indirect Direct) | View |
2023-11-13 Purchase | 2023-11-13 7:11 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner | 849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 1,644 | $39.8 | 4,281,533 (Direct) | View |
2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 5,804 | $17 | 4,281,533 (Direct) | View |
2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,418 | $10.73 | 4,281,533 (Direct) | View |
2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,418 | $13.22 | 4,281,533 (Direct) | View |
2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 12,284 | $0 | 4,281,533 (Direct) | View |
2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 357 | $39.8 | 3,005,777 (Direct) | View |
2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 1,262 | $17 | 3,005,777 (Direct) | View |
2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 526 | $10.73 | 3,005,777 (Direct) | View |
2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 526 | $13.22 | 3,005,777 (Direct) | View |
2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,671 | $0 | 3,005,777 (Direct) | View |
2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 277 | $39.8 | 3,297,625 (Direct) | View |
2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 994 | $17 | 3,297,625 (Direct) | View |
2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 414 | $10.73 | 3,297,625 (Direct) | View |
2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 414 | $13.22 | 3,297,625 (Direct) | View |
2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,099 | $0 | 3,297,625 (Direct) | View |
2024-02-29 Other | 2024-03-04 7:31 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner | 1,016,200 | $0 | 5,009,239 (Direct) | View |